BCL2 and neoplasm: Zhuang et al. [29] reported that miR-202 acts as a tumor suppressor in hepatocellular carcinoma by reducing BCL2 expression, noting a significant decrease in miR-202 in hepatocellular tissues and cell lines, with a concomitant increase in BCL2 expression.